|
Play Video: The Importance of Insider Buying
|
|
|
The table below summarizes the most recent Yield10 Bioscience insider buying information, with links below the price to see the
CAGR achieved by each insider on their purchases. As the saying goes on Wall St., there are many
possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more
information about why Yield10 Bioscience insider buys are important for investors to follow.
Date | Insider | Price | Amount |
8-15-2023 Insider Buy |
Jack W. Schuler
|
$0.65
CAGR »
|
$497,250.00 765,000 shares |
5-5-2023 Insider Buy |
Jack W. Schuler
|
$2.98
CAGR »
|
$999,998.60 335,570 shares |
8-17-2022 Insider Buy |
Anthony J. Sinskey Director |
$2.80
CAGR »
|
$16,827.20 6,000 shares |
3-14-2022 Insider Buy |
Anthony J. Sinskey Director |
$6.23
CAGR »
|
$6,230.00 1,000 shares |
12-3-2021 Insider Buy |
Charles B. Haaser VP Fin and CAO |
$4.20
CAGR »
|
$10,079.76 2,400 shares |
12-3-2021 Insider Buy |
Anthony J. Sinskey Director |
$4.48
CAGR »
|
$17,916.00 4,000 shares |
2-3-2021 Insider Buy |
Jack W. Schuler >10% Owner |
$12.25
CAGR »
|
$1,242,150.00 101,400 shares |
8-26-2020 Insider Buy |
Jack W. Schuler >10% Owner |
$4.25
CAGR »
|
$1,552,274.25 365,241 shares |
2-11-2020 Insider Buy |
Jack W. Schuler >10% Owner |
$7.91
CAGR »
|
$77,880.06 9,852 shares |
9-3-2019 Insider Buy |
Oliver P. Peoples Pres & CEO |
$0.82
CAGR »
|
$8,200.00 10,000 shares |
8-1-2019 Insider Buy |
Oliver P. Peoples Pres & CEO |
$0.92
CAGR »
|
$9,200.00 10,000 shares |
7-5-2019 Insider Buy |
Oliver P. Peoples Pres & CEO |
$0.88
CAGR »
|
$8,800.00 10,000 shares |
3-14-2019 Insider Buy |
Jack W. Schuler >10% Owner |
$2.02
CAGR »
|
$4,977,733.35 2,459,171 shares |
7-3-2017 Insider Buy |
Jack W. Schuler >10% Owner |
$4.00
CAGR »
|
$741,568.00 185,392 shares |
Also See: Institutional Holders of YTEN
Also See: SEC filings
Below we present the annualized performance delivered by Yield10 Bioscience stock since 8-15-2023 (the date of the most recent
insider purchase). The performance of the investment from the time Yield10 Bioscience insider buying occurred is the ultimate
test of whether insiders were right about YTEN being a good buy.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
08/16/2023 |
|
End date: |
05/01/2024 |
|
Start price/share: |
$0.43 |
|
End price/share: |
$0.22 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-48.84% |
|
Annualized Gain: |
-68.82% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$5,116.00 |
|
Years: |
0.71 |
|
Yield10 Bioscience Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.),
and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these
categories, but instead file their holdings quarterly on the latest form 13F filings.
While recent Yield10 Bioscience insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding YTEN
|
|